The legislation that has been proposed by the bi-partisan and bi-cameral Prescription Drug Task Force earlier this year continues to progress. SB 11 has been referred to the Senate Committee on Finance and HB 7192 is currently on the house calendar. HB 7192 aims to enhance the accountability and transparency of PBMs and health carriers, implementing recommendations from the Bipartisan Drug Task Force. NACDS participated in the task force and submitted testimony when both bills had hearings. NACDS will continue to advocate for PBM policy priorities throughout the legislative session.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.